These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31678469)

  • 21. Diphenylcyclopropenone immunotherapy in ophiasis.
    Singh G; Okade R; Naik C; Dayanand CD
    Indian J Dermatol Venereol Leprol; 2007; 73(6):432-3. PubMed ID: 18032873
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of alopecia areata with diphenylcyclopropenone].
    Ochsendorf FR; Mitrou G; Milbradt R
    Z Hautkr; 1988 Feb; 63(2):94, 96, 99-100. PubMed ID: 3376515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone.
    van der Steen PH; van Baar HM; Happle R; Boezeman JB; Perret CM
    J Am Acad Dermatol; 1991 Feb; 24(2 Pt 1):227-30. PubMed ID: 2007667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alopecia areata].
    Friedli A; Harms M
    Ther Umsch; 2002 May; 59(5):233-7. PubMed ID: 12090120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired responses of peripheral blood mononuclear cells to T-cell stimulants in alopecia areata patients with a poor response to topical immunotherapy.
    Yoshino T; Asada H; Ando Y; Fujii H; Yamaguchi Y; Yoshikawa K; Itami S
    Br J Dermatol; 2001 Sep; 145(3):415-21. PubMed ID: 11531830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of topical diphenylcyclopropenone maintenance treatment for patients with alopecia areata: A retrospective study.
    Choe SJ; Lee S; Lee H; Choi J; Lee WS
    J Am Acad Dermatol; 2018 Jan; 78(1):205-207.e1. PubMed ID: 29241788
    [No Abstract]   [Full Text] [Related]  

  • 29. Topical immunotherapy with diphenylcyclopropenone-induced vitiligo.
    Kutlubay Z; Engin B; Songur A; Serdaroglu S; Tuzun Y
    J Cosmet Laser Ther; 2016 Aug; 18(4):245-6. PubMed ID: 26963903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of alopecia areata in children.
    Mukherjee N; Burkhart CN; Morrell DS
    Pediatr Ann; 2009 Jul; 38(7):388-95. PubMed ID: 19685659
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients.
    Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical immunotherapy of alopecia areata.
    van der Steen PH; Happle R
    Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
    Naldi L; Parazzini F; Cainelli T
    J Am Acad Dermatol; 1990 Apr; 22(4):654-6. PubMed ID: 2138637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic extensive alopecia areata by diphenylcyclopropenone alone versus in combination with anthralin.
    Ibrahim SA; Esawy AM; Abdelshafy AS
    Dermatol Ther; 2019 Sep; 32(5):e13010. PubMed ID: 31237076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series.
    Nasimi M; Ghandi N; Abedini R; Mirshamsi A; Shakoei S; Seirafi H
    Arch Dermatol Res; 2019 Oct; 311(8):607-613. PubMed ID: 31165933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of alopecia areata with diphenylcyclopropenone].
    Kietzmann H; Hardung H; Christophers E
    Hautarzt; 1985 Jun; 36(6):331-5. PubMed ID: 3160683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical immunotherapy with diphenylcyclopropenone in patients with alopecia areata: A large retrospective study of 757 patients.
    Nasimi M; Abedini R; Ghandi N; Seirafi H; Mehdizade MS; Tootoonchi N
    Dermatol Ther; 2020 Nov; 33(6):e13808. PubMed ID: 32530566
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC; Traupe H; Luger TA; Böhm M
    J Eur Acad Dermatol Venereol; 2012 Apr; 26(4):503-7. PubMed ID: 21569118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.